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A B S T R A C T
The heptose-deﬁcient inner core of the lipopolysaccharide of several pathogenic strains of theMoraxellaceae
family (Moraxella, Acinetobacter) and of Bartonella henselae, respectively, comprises an α-D-glucopyranose
attached to position 5 of Kdo. In continuation of the synthesis of fragments of Acinetobacter haemolyticus
LPS, the branched α-Glcp-(1→5)[α-Kdo-(2→4)]-α-Kdo trisaccharidemotif was elaborated. The glycosylation
of a suitably protected, α-(2→4)-interlinked Kdo-disaccharide was achieved in high yield and fair anomeric
selectivity using a 4,6-O-benzylideneN-phenyltriﬂuoroacetimidate glucosyl donor. Subsequent regioselective
reductive benzylidene opening afforded a trisaccharide acceptor, which was extended with β-D-
glucopyranosyl and isomaltosyl residues. Global deprotection provided tri- to pentasaccharide structures
corresponding to the inner core region of A. haemolyticus lipopolysaccharide.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
The Gram-negative bacterial cell wall is covered by densely
packed lipopolysaccharide (LPS) molecules, which trigger major
immune responses of the respective host during pathogenesis.1,2
In structural terms, these glycolipids comprise the endotoxically
active lipid anchor (lipid A) and an extended oligosaccharide frac-
tion, which harbors a core region of limited structural variability
and the strain-speciﬁc, highly diverse O-antigenic polysaccharides.3,4
The core domain may be further divided into an outer and an
inner core region, wherein a 3-deoxy-d-manno-2-octulosonic acid
(Kdo) usually forms the link to the lipid A part. In many bacterial
genera, this Kdo unit is extended by a lateral α-(2→4)-linked Kdo
moiety.5 In a few cases—such as in some Acinetobacter strains—Kdo
is non-stoichiometrically replaced by its 3-oxy analogue d-glycero-
d-talo-2-octulosonic acid (Ko).6 The α-(2→4)-Kdo disaccharide is
frequently substituted at position 5 by a l-glycero-d-manno-
heptose residue, and d-mannose, d-galactosamine and Kdo itself
were also occasionally identiﬁed as the branching sugar.7 Speciﬁ-
cally, an α-(1→5)-linked d-glucopyranosyl residue has been found
in LPS of the Moraxellaceae family and was shown to elicit
cross-reactive antibodies recognizing different serotypes.8 In
addition, Bartonella henselae—the causative agent of the cat-
scratch disease—expresses a truncated core region being composed
of α-Glcp-(1→5)[α-Kdo-(2→4)]-α-Kdo linked to lipid A.9 Further-
more, in A. haemolyticus, this basic trisaccharide pattern is elongated
at the glucose unit by a β-(1→4)-linked isomaltotriose.10 The ob-
servation of a high binding aﬃnity of isolated inner core fragments
from A. haemolyticus toward different mannose binding lectins11
prompted us to synthesize part structures thereof in order to
identify the relevant binding epitopes.
Previously, stereoselective α-(1→5)-coupling of glucosyl donors
to Kdo monosaccharide acceptors was successfully performed by
Oscarson using a thioglycoside donor in the presence of DMTST.12
In a previous contribution we have capitalized on the use of an
NPTFA-glucosyl donor and an orthogonal blocking group at
position-4 of Kdo to allow for the introduction of the lateral
Kdo at a later stage.13 A limited number of papers has been
published addressing the synthesis of 5-O-glycosylated α-Kdo-
(2→4)-α-Kdo disaccharides.14 Ichiyanagi et al recently reported
on the convenient preparation of 5-O-substituted Kdo disaccha-
rides applying a Kdo disaccharide acceptor for coupling with
heptose, d-mannose and 2-azido-2-deoxy-d-galactose (as a pre-
cursor for d-galactosamine) donors.15 Extending these studies, we
present herein a high-yielding method to access the branched
α-Glcp-(1→5)[α-Kdo-(2→4)]-α-Kdo trisaccharide with fair
stereoselectivity and its subsequent elongation into tetra- and
pentasaccharide derivatives.
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2. Results and discussion
2.1. Approach A: using an α-Glc-(1→5)-Kdo acceptor
Previously, α-Glc-(1→5)-Kdo disaccharide 1 has been prepared
with excellent stereoselectivity and in a high yield.13 The orthogo-
nal protecting group pattern allowed for selective cleavage of the
p-methoxybenzyl group (PMB) affording the 4-OH Kdo acceptor 2.
Starting from 2 we envisaged to introduce the lateral Kdo moiety
using the Kdo ﬂuoride donors 3 and 4, which were recently re-
ported to yield only α-anomeric products without signiﬁcant
elimination side reaction.16 Speciﬁcally, the per-O-acetyl pro-
tected Kdo donor 3 proved to be an eﬃcient glycosyl donor for
regioselective coupling to a 4,5-diol Kdo acceptor yielding the
α-(2→4)-interconnected Kdo disaccharide as a single isomer in high
yield.16a The donor, however, was unreactive in the presence of base—
such as triethylamine or sym-collidine—whichwere added to capture
hydrogen ﬂuoride. Since the 7,8-O-disiloxane-1,3-diyl (TIPDS) and
the 4,6-O-acetal group in acceptor 2 were not compatible with
glycosylation conditions lacking a HF-scavenger, these protecting
groups were replaced by acetyl groups. Accordingly, acid hydroly-
sis of the benzylidene group, followed by cleavage of the silyl ether,
O-acetylation and DDQ-oxidation of the PMB group furnished the
disaccharide acceptor 5 in 40% overall yield (Scheme 1). Attempted
coupling of 5 with acetyl-protected donor 3 under BF3·Et2O pro-
motion (2 eq.) in dichloromethane in the presence of 3 Å molecular
sieves at room temperature, however, failed and trisaccharide for-
mation was not detected.
Next, the armed benzylated donor 4 was tried, which had been
shown to react with 2-propanol under BF3·Et2O promotion also in
the presence of triethylamine, although higher temperatures were
necessary.16b First, when using donor 4 in the absence of base and
under conditions as used for donor 3, degradation of acceptor 2 was
observed. In the presence of triethylamine, acceptor 2 was unaf-
fected, but glycosylation did not take place. In a last attempt, we
intended to exploit the high reactivity of 4 and the compatibility
of glycosyl acceptor 5 toward base-free conditions. Again, however,
glycoside formation could not be achieved. NMR analysis of 5 re-
vealed a through-space interaction between the axial hydrogen at
position-3 of Kdo with H-5′ of the glucosyl residue (Fig. 1). This
would indicate that the glucose unit is in close proximity to the Kdo
ring and thus sterically shields the 4-OH group toward the incom-
ing electrophile.
In addition to the Kdo-ﬂuoride based glycosylation attempts, cou-
pling of acceptor 2 with peracetylated Kdo bromide under Helferich
conditions was also tested, but did not lead to signiﬁcant product
formation. Previously, this approach had successfully been per-
formed for the introduction of a lateral Kdo-unit onto a l-glycero-
d-manno-heptosyl-(1→5)-Kdo glycosyl acceptor in 65% yield.17
2.2. Approach B: using an α-Kdo-(2→4)-Kdo acceptor
As an alternative approach, the sequence of glycosylation steps
was inverted by attaching a suitably protected glucose donor to a
preassembled α-Kdo-(2→4)-Kdo disaccharide acceptor. Thus, we
could capitalize on the previously elaborated route toward Kdo2 7,
which was obtained in high yields and without any formation of
β-products.16a Recently, Ichiyanagi et al successfully coupled a Kdo2
5-OH acceptor with heptose and mannose trichloroacetimidate
donors exploiting the trans-directing effect of C-2 ester groups.15 First,
the 5-OH acceptor 8 was obtained from iodo-precursor 7 by
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Fig. 1. Section of the NOESY spectrum of compound 5 in CDCl3 showing a corre-
lation between H-3ax and H-5′.
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hydrogen atom transfer18 in cyclohexane catalyzed by lauroyl per-
oxide. Previously, dehalogenation depended on fully blocked
compounds to guarantee suﬃcient solubility in cyclohexane for
smooth conversion.16a Notably, using a mixture of cyclohexane and
1,2-dichloroethane18 allowed for direct and neat dehalogenation of
disaccharide 7, which provided acceptor 8 in high yield (92%).
In previous experiments, N-phenyltriﬂuoroacetimidate glucose
donor 613 afforded excellent α-selectivity in the glycosylation of a
5-OH Kdo monosaccharide due to the directing effect of the 4,6-
O-benzylidene group.19 Coupling of 5-OH acceptor 8 with donor 6
in CH2Cl2 under TMSOTf catalysis in the presence of ground 4 Åmo-
lecular sieves provided traces of both α- and β-trisaccharides 9α
and 9β. By exploiting the known20 1,2-cis directing effect of ether
solvents, the α/β-ratio could be increased signiﬁcantly (from
α/β = 1:1.2 in CH2Cl2 to 2.7:1 in Et2O in preliminary experiments).
The observation that glycoside formation ceased after a short initial
phase led to the assumption that TfOH formed by partial hydroly-
sis of TMSOTf was the active promoter, which would then be rapidly
scavenged by 4 Å molecular sieves. Indeed, applying TfOH as acti-
vator in the presence of 5 Åmolecular sieves improved the total yield
to 31%. This still disappointing outcomewas attributed to donor deg-
radation that proceeded faster than glycoside formation. Eventually,
using inverse glycosylation conditions21 in diethyl ether contain-
ing molecular sieves (5 Å) afforded a mixture of anomers 9α and
9β in a total yield of 91% (α/β = 4:1), which could be conveniently
separated on an HPLC column (isolated yield of α-product 9α: 67%).
The α-anomeric conﬁguration was readily assigned on the basis of
the coupling constant J1″,2″ (3.8 Hz). Lactone formation between C-1′
of the lateral Kdo unit and the free 5-hydroxyl group was also ob-
served, but to a low degree only. Sequential removal of benzyl (Pd/
C, H2) and acetyl (NaOMe) groups from trisaccharide 9α and ensuing
methyl ester saponiﬁcation under alkaline conditions (NaOH) gave
trisaccharide 10 in 94% yield (Scheme 2).
2.3. Synthesis of oligoglucosyl fragments
Proceeding toward the oligoglucosyl core structures, regioselective
opening of the benzylidene group in compound 9α to provide the
6-OBn protected derivative 11 was foreseen, to serve as an accep-
tor for the extended glucosyl core structure of A. haemolyticus.
Hence, treatment of trisaccharide9αwith triethylsilane/BF3.Et2O22
in dry dichloromethane afforded the desired 4-OH acceptor deriv-
ative11as themajorproduct (72%) togetherwith its 6-OHregioisomer
12 (5%) and traces of diol 13 (2%). By using the peracetylated
glucopyranosyl NPTFA donor 1423 under TfOH promotion (5 mol%
for15, 12.5mol% for18), tetrasaccharide15wasobtained (Scheme3).
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Scheme 2. Reagents and conditions: a) Lauroyl peroxide, cyclohexane/ClCH2CH2Cl (7.2:1), reﬂux, 2 h, 92%; b) TfOH, 5 Å molecular sieves, CH2Cl2/Et2O (2:1), r.t., 3 h, 91%
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The isolatedyield for theβ-tetrasaccharide14, however, didnot exceed
46%, since several puriﬁcation steps byHPLCwere needed to produce
a pure tetrasaccharide. Using the same strategywith the isomaltosyl
donor 17, the pentasaccharide 18 was readily accessible in a 3+2
approach in a good yield (71%). Global deprotection afforded the oli-
gosaccharide ligands 16 (99%) and 19 (90%) in excellent yields. The
13C NMR data of the oligosaccharide (Table 1) are in good agree-
ment with the LPS-oligosaccharides isolated from B. henselae ATCC
49882T* and A. haemolyticus, respectively.9,10 Deviating assign-
ments were only noted for C-7 of both Kdo units.9
2.4. Conclusions and outlook
In summary, a straightforward method to prepare the α-Glcp-
(1→5)[α-Kdo-(2→4)]-α-Kdo trisaccharide capitalizing on a Kdo
disaccharide acceptor was established. Good α-selectivity relied on
diethyl ether as a solvent and high yields were obtained by slowly
adding the donor to a pre-stirred mixture of the Kdo2 acceptor and
TfOH as a promotor. The 4,6-O-benzylidene blocking group of the
donor eventually provided access to extended oligosaccharides after
regioselective reductive opening. Subsequent elongation with 2-O-
acetyl protected N-phenyl triﬂuoroacetimidate glucosyl donors
allowed for the introduction of β-Glcp-(1→4)- as well as α-Glcp-
(1→6)-β-Glcp-(1→4)- units. Thus, three fragments of the A.
haemolyticus inner core were obtained which serve as ligands in
binding studies with C-type collectins.
3. Experimental
3.1. General
All purchased chemicals were used without further puriﬁca-
tion unless stated otherwise. The promoter BF3·Et2O was used as a
solution in diethyl ether (≥46% according to the manufacturer). Sol-
vents were dried over activated 3 Å (acetone, Et2O) or 4 Å (CH2Cl2,
ClCH2CH2Cl, cyclohexane, N,N-dimethylformamide, pyridine) mo-
lecular sieves. Dry MeOH (Merck) and dry THF (Sigma-Aldrich) were
purchased. Cation exchange resin DOWEX 50 H+ was regenerated
by consecutive washing with HCl (3 M), water and dry MeOH.
Aqueous solutions of salts were saturated unless stated other-
wise. Concentration of organic solutions was performed under
reduced pressure <40 °C. Optical rotations were measured with a
Perkin-Elmer 243 B Polarimeter. [α]D20 values are given in units of
10−1deg cm2g−1. Thin layer chromatography was performed onMerck
precoated plates: generally on 5 × 10 cm, layer thickness 0.25 mm,
Silica Gel 60F254; alternatively on HPTLC plates with 2.5 cm con-
centration zone (Merck). Spots were detected by dipping reagent
(anisaldehyde-H2SO4). For column chromatography silica gel (0.040–
0.063 mm) was used. HP-column chromatography was performed
on pre-packed columns (YMC-Pack SIL-06, 0.005mm, 250 × 10mm
and 250 × 20 mm). Desalting after ester saponiﬁcation was per-
formed on pre-packed PD-10 columns (GE Healthcare, SephadexTM
G-25 M). NMR spectra were recorded with a Bruker Avance III 600
instrument (600.22 MHz for 1H, 150.93 MHz for 13C) using stan-
dard Bruker NMR software. 1H spectrawere referenced to 7.26 (CDCl3)
and 0.00 (D2O, external calibration to 2,2-dimethyl-2-silapentane-
5-sulfonic acid) ppm unless stated otherwise. 13C spectra were
referenced to 77.00 (CDCl3) and 67.40 (D2O, external calibration to
1,4-dioxane) ppm. ESI-MS datawere obtained on aWatersMicromass
Q-TOF Ultima Global instrument.
3.2. 4,6-Di-O-acetyl-2,3-di-O-benzyl-α-D-glucopyranosyl-
(1→5)-methyl (methyl 7,8-di-O-acetyl-3-deoxy-α-D-manno-oct-2-
ulopyranosid)onate (5)
A solution of disaccharide 113 (100mg, 0.094mmol) in dryMeOH
(4.0 mL) containing p-toluenesulfonic acid-monohydrate (1.6 mg,
0.008mmol) was kept at 40 °C for 2 h under an atmosphere of argon.
The cooled solution was treated with solid NaHCO3 (ca. 50 mg) for
5 min, the solvent was removed under reduced pressure and the
residue was partitioned between EtOAc and aq. NaHCO3. The organic
phase was washed with brine, dried (MgSO4), ﬁltered and concen-
trated. The residue was dissolved in dry THF (6.0 mL) and treated
with tetrabutylammonium ﬂuoride (1 M in THF, 0.14 mL,
0.142mmol) at 0 °C for 20min. After addition of dry MeOH (1.0mL),
the solvent was removed and EtOAc was added. The residue was
ﬁltered over a short pad of silica and rinsed with EtOAc. Concen-
tration of the ﬁltrate afforded a crude product, which was acetylated
using acetic anhydride (0.8 mL), 4-(N,N-dimethylamino)pyridine
(5 mg) and dry pyridine (4.0 mL). After 14 h at ambient tempera-
ture excessive reagent was destroyed with dry MeOH (1.0 mL) at
0 °C (10 min) followed by removal of solvent by codistillation with
toluene (3×). Chromatography of the crude product provided the
PMB-protected intermediate (52 mg, 61%) as a colorless oil.
This intermediate (41 mg, 0.046 mmol) was dissolved in dry
CH2Cl2 (2.1 mL) and dry MeOH (0.7 mL) under Ar and treated with
2,3-dichloro-5,6-dicyano-1,4-benzoquinone (164 mg, 0.672 mmol)
in eight portions within 2.5 h. After complete addition, the mixture
was stirred for 1 h, diluted with CHCl3 and washed with aq. NaHCO3.
The aqueous phase was once more extracted with CHCl3 and the
combined organic phases were washed with aq. NaHCO3 (2×), dried
(MgSO4) and ﬁltered. Concentration of the ﬁltrate and puriﬁcation
of the residue by chromatography (toluene/EtOAc 9:1 to remove
Table 1
13C NMR chemical shifts (δ) of compounds 10, 16 and 19
Residue Carbon 10 16 19
→4,5)-α-Kdop
1 176.05 175.94 176.05b
2 101.35 101.35 101.34
3 35.24 35.21 35.19
4 72.12 72.04a 72.04c
5 74.47 73.94 73.78
6 73.22 73.11 73.10
7 69.26 69.35 69.29
8 63.98 64.00 64.08
α-Kdop-(2→4)-
1 176.05 176.03 175.92b
2 102.87 102.82 102.84
3 35.42 35.48 35.50
4 66.67 66.73 66.75
5 67.68 67.66 67.67
6 72.50 72.55 72.55d
7 71.52 71.50 71.52
8 63.58 63.82 63.63
α-Glcp-(1→5)-
1 100.31 99.72 99.61
2 72.88 72.60 72.45
3 73.29 71.90a 72.03c
4 69.76 79.07 79.98
5 72.64 71.25 71.06
6 60.69 60.29 60.30
β-Glcp-(1→4)-
1 103.36 103.69
2 73.94 73.81
3 76.33 76.40
4 70.33 70.49
5 76.78 74.97
6 61.46 66.74
α-Glcp-(1→6)-
1 98.79
2 72.32
3 73.62
4 70.49
5 72.71d
6 61.39
OCH3 51.37 51.38 51.37
a–d Assignments within a column may be reversed.
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excessive reagent, then 2:1 to elute product) afforded 4-OH accep-
tor 5 (23 mg, 65%, total yield: 40%) as a colorless oil: [α]D20 + 41.9
(c 0.56, CHCl3); Rf 0.18 (n-hexane/EtOAc 1:1); 1H NMR (CDCl3): δ 7.36–
7.27 (m, 10H, Ar), 5.43 (app dt, 1H, J7,6 ~ 5.7, J7,8a 2.1 Hz, H-7), 4.87
(app t, 1H, J4′,3′ ~ J4′,5′ 9.5 Hz, H-4′), 4.86 (d, 1H, J1′,2′ 3.7 Hz, H-1′), 4.85
(d, 1H, J 11.1 Hz, CHHPh), 4.82 (dd, 1H, J8a,8b 12.5 Hz, H-8a), 4.74 (d,
1H, J 12.2 Hz, CHHPh), 4.70 (d, 1H, J 12.4 Hz, CHHPh), 4.68 (d, 1H, J
11.6 Hz, CHHPh), 4.29 (dd, 1H, J8b,7 5.3 Hz, H-8b), 4.10 (dt, 1H, J5′,6′
4.6 Hz, H5′), 4.07–4.00 (m, 3H, H-4, H-6′a, H-6′b), 3.98–3.96 (br s,
1H, H-5), 3.95 (dd, J6,5 1.0 Hz, H-6), 3.93 (app t, 1H, H-3′), 3.83 (s,
3H, CO2CH3), 3.56 (dd, 1H, J2′,3′ 9.5, J2′,1′ 3.5 Hz, H-2′), 3.37 (d, 1H, JOH,4
11.5 Hz, OH), 3.27 (s, 3H, OCH3), 2.20–2.16 (m, 1H, H-3eq), 2.03, 2.01,
1.95 and 1.94 (4 s, each 3H, COCH3), 1.80 (app t, 1H, J3ax,3eq ~ J3ax,4
12.5 Hz, H-3ax); 13C NMR (CDCl3): δ 170.53, 170.43, 169.95 and
169.76 (4 s, 4C, COCH3), 168.02 (s, C-1), 138.39 and 137.85 (2 s, 2C,
Ar), 128.56, 128.39, 128.00, 127.95, 127.67 and 127.63 (6 d, 10C, Ar),
99.73 (d, C-1′), 99.04 (s, C-2), 79.42 (d, C-5), 78.79 (d, C-3′), 78.30
(d, C-2′), 75.17 (t, CH2Ph), 73.73 (t, CH2Ph), 71.54 (d, C-6), 71.13 (d,
C-7), 69.90 and 69.51 (2 d, 2C, C-4′, C-5′), 66.19 (d, C-4), 62.84 (t,
C-6′), 62.25 (t, C-8), 52.62 (q, CO2CH3), 51.04 (q, OCH3), 36.08 (t, C-3′),
21.02, 20.76, 20.70 and 20.63 (4 q, 4C, COCH3); ESI-TOF HRMS:
m/z = 799.2784; calcd for C38H48O17Na+: 799.2784.
3.3. Methyl (4,5,7,8-tetra-O-acetyl-3-deoxy-α-D-manno-oct-2-
ulopyranosyl)onate-(2→4)-methyl (methyl 7,8-O-carbonyl-3-deoxy-
α-D-manno-oct-2-ulopyranosid)onate (8)
A suspension of disaccharide 716a (0.71 g, 0.87mmol) in amixture
of dry ClCH2CH2Cl (9.0 mL) and dry cyclohexane (65.0 mL) was de-
gassed with argon and heated to reﬂux for 15min. Lauroyl peroxide
(0.12 g, 0.30 mmol) was added to the warm solution and then re-
ﬂuxed for 2 h. The solvent was removed under reduced pressure and
the residue was subjected to chromatography (n-hexane/EtOAc 1:2)
to provide dehalogenated compound 8 (0.56 g, 92%) as a colorless
amorphous solid: [α]D20 + 73.1 (c 0.63, CHCl3); Rf 0.31 (toluene/
EtOAc 2:3); 1H NMR (CDCl3): δ 5.40–5.38 (m, 1H, H-5′), 5.26–5.19
(m, 2H, H-4′, H-7′), 4.91 (ddd, 1H, J7,8b 8.2, J7,8a 6.9 Hz, J7,6 3.7, H-7),
4.75 (dd, 1H, J8a,8b 8.9, H-8a), 4.65 (dd, 1H, J8′a,8′b 12.5, J8′a,7′ 2.7 Hz,
H-8′a), 4.54 (app t, 1H, H-8b), 4.25 (ddd, 1H, J4,3ax 11.2, J4,3eq 5.7, J4,5
3.2 Hz, H-4), 4.11 (dd, 1H, J6′,7′ 9.6, J6′,5′ 1.3 Hz, H-6′), 4.08 (dd, 1H,
J8′b,7′ 3.5 Hz, H-8′b), 3.89–3.87 (m, 1H, H-6), 3.84 (s, 3H, CO2CH3), 3.81
(s, 3H, CO2CH3), 3.69–3.67 (m, 1H, H-5), 3.22 (s, 3H, OCH3), 2.46 (bs,
1H, OH), 2.20 (dd, 1H, J3′eq,3′ax ~ J3′eq,4′ 12.7, H-3′eq), 2.13 (s, 3H, COCH3),
2.12–2.03 (m, 6H, H-3ax, H-3′ax, H-3eq, COCH3), 2.00 and 1.98 (2 s,
each 3H, COCH3); 13C NMR (CDCl3): δ 170.98, 170.20, 169.88 and
169.61 (4 s, 4C, COCH3), 168.87 and 167.58 (2 s, 2C, C-1, C-1′), 154.66
[s, OC(=O)O], 99.10 and 98.08 (2 s, 2C, C-2, C-2′), 76.03 (d, C-7), 70.38
(d, C-6), 69.61 (d, C-6′), 67.64 and 67.45 (2 d, 2C, C-4, C-7′), 66.10
(t, C-8), 65.88 (d, C-4′), 64.73 (d, C-5), 64.18 (d, C-5′), 61.58 (t, C-8′),
53.43 and 52.71 (2 q, 2C, CO2CH3), 51.14 (q, OCH3), 33.00 and 32.29
(2 t, 2C, C-3, C-3′), 20.70, 20.60, 20.58 and 20.56 (4 q, 4C, COCH3);
ESI-TOF HRMS: m/z = 712.2298; calcd for C28H38O20NH4+: 712.2295.
3.4. Methyl (4,5,7,8-tetra-O-acetyl-3-deoxy-α-D-manno-oct-2-
ulopyranosyl)onate-(2→4)-[2,3-di-O-benzyl-4,6-O-benzylidene-α-D-
glucopyranosyl-(1→5)]-methyl (methyl 7,8-O-carbonyl-3-deoxy-α-
D-manno-oct-2-ulopyranosid)onate (9α) and methyl
(4,5,7,8-tetra-O-acetyl-3-deoxy-α-D-manno-oct-2-
ulopyranosyl)onate-(2→4)-[2,3-di-O-benzyl-4,6-O-benzylidene-β-D-
glucopyranosyl-(1→5)]-methyl (methyl 7,8-O-carbonyl-3-deoxy-α-
D-manno-oct-2-ulopyranosid)onate (9β)
A solution of disaccharide acceptor 8 (77mg, 0.111mmol) in dry
Et2O (1.5 mL) containing ground 5 Å molecular sieves (75 mg) was
stirred at ambient temperature for 2 h under Ar. Diluted triﬂic acid
(0.49 μL, 5.55 μmol) in dry CH2Cl2 (0.1mL) was added and after 5min,
a separately prepared solution of donor 613 (344 mg, 0.555 mmol)
in dry CH2Cl2 (3.0 mL) was added to this mixture using a syringe
pump (1 mL/h). After complete addition, the promoter was neu-
tralized by adding triethylamine (32 μL, 0.222 mmol) and the
suspension was ﬁltered over Celite. The ﬁltrate was concentrated
and the residual solid was puriﬁed by chromatography (n-hexane/
EtOAc 1:1) affording a mixture of the anomers 9α and 9β (114 mg,
91%, α:β = 4:1 according to 1H NMR). The compounds were sepa-
rated on an HPLC column (toluene/EtOAc 3:1 → 2:1) providing the
desired α-anomer 9α (83 mg, 67%) and the slower migrating
β-isomer 9β (20mg, 16%) as colorless oils. Data for 9α: [α]D20 + 111.4
(c 0.82, CHCl3); Rf 0.44 (toluene/EtOAc 2:1, HP-TLC); 1H NMR (CDCl3):
δ 7.51–7.28 (m, 15H, Ar), 5.58 (s, 1H, PhCH), 5.35–5.33 (m, 1H, H-5′),
5.27 (ddd, 1H, J4′,3′ax 12.5, J4′,3′eq 4.8, J4′,5′ 3.0 Hz, H-4′), 5.19 (ddd, 1H,
J7′,6′ 9.6, J7′,8′b 3.9, J7′,8′a 2.8 Hz, H-7′), 5.07 (d, 1H, J1″,2″ 3.8 Hz, H-1″),
5.00 (d, 1H, J 11.5 Hz, CHHPh), 4.92 (d, 1H, J 10.6 Hz, CHHPh), 4.85
(d, 1H, J 11.5 Hz, CHHPh), 4.67 (dd, 1H, J8′a,8′b 12.4 Hz, H-8′a), 4.66–
4.62 (m, 1H, H-7), 4.59 (d, 1H, J 10.9 Hz, CHHPh), 4.44 (dd, 1H, J8a,8b
8.6, J8a,7 5.8 Hz, H-8a), 4.30 (dd, 1H, J6″a,6″b 10.4, J6″a,5″ 4.8 Hz, H-6″a),
4.20 (dd, 1H, J6′,5′ 1.5 Hz, H-6′), 4.16 (ddd, 1H, J4,3ax 11.8, J4,3eq 4.7, J4,5
2.4 Hz, H-4), 4.06 (app t, 1H, J8b,7 ~ 8.4 Hz, H-8b), 4.01 (dd, 1H, H-8′b),
3.93–3.88 (m, 2H, H-3″, H-5″), 3.84 (s, 3H, CO2CH3), 3.83–3.82 (m,
1H, H-5), 3.79 (s, 3H, CO2CH3), 3.75–3.69 (m, 2H, H-6, H-6″b), 3.66
(app t, 1H, J4″,3″ ~ J4″,5″ 9.3 Hz, H-4″), 3.59 (dd, 1H, H-2″), 3.16 (s, 3H,
OCH3), 2.21–2.15 (m, 2H, H-3eq, H-3′eq), 2.10 (app. t, 1H, J3ax,3eq ~
12.1 Hz, H-3ax), 2.09 and 2.07 (2 s, each 3H, COCH3), 2.07 (app t, 1H,
J3′ax,3′eq 12.7 Hz, H-3′ax), 1.99 and 1.95 (2 s, each 3H, COCH3); 13C NMR
(CDCl3): δ 170.85, 170.27, 169.69 and 169.60 (4 s, 4C, COCH3), 168.06
and 167.35 (2 s, 2C, C-1, C-1′), 154.57 [s, OC(=O)O], 138.24, 137.70
and 137.28 (3 s, 3C, Ar), 128.95, 128.64, 128.46, 128.33, 128.25,
128.23, 128.20, 127.93 and 125.99 (9 d, 15C, Ar), 101.28 (d, PhCH),
100.56 (d, C-1″), 99.34 and 98.92 (2 s, C-2, C-2′), 82.63 (d, C-4″), 79.86
(d, C-2″), 77.86 (d, C-3″), 76.00 (d, C-5), 75.16 (d, C-7), 75.01 (t, CH2Ph),
74.81 (t, CH2Ph), 72.03 (d, C-6), 69.50 (d, C-4), 69.44 (d, C-6′), 68.95
(t, C-6″), 67.72 (d, C-7′), 65.95 (t, C-8), 65.92 (d, C-4′), 64.37 (d, C-5′),
63.59 (d, C-5″), 61.58 (t, C-8′), 53.11 and 52.69 (2 q, 2C, CO2CH3),
51.23 (q, OCH3), 33.85 (t, C-3), 32.40 (t, C-3′), 20.70, 20.63 and 20.58
(3 q, 4C, 4 COCH3); ESI-TOF HRMS: m/z = 1147.3625; calcd for
C55H64O25Na+: 1147.3629.
9β: [α]D20 + 49.8 (c 0.82, CHCl3); Rf 0.23 (toluene/EtOAc 2:1, HP-
TLC); 1H NMR (CDCl3): δ 7.49–7.24 (m, 15H, Ar), 5.56 (s, 1H, PhCH),
5.35–5.33 (m, 1H, H-5′), 5.23 (ddd, 1H, J4′,3′ax 12.3, J4′,3′eq 4.9, J4′,5′ 3.0 Hz,
H-4′), 5.18 (ddd, 1H, J7′,6′ 9.2, J7′,8′b 4.3, J7′,8′a 2.8 Hz, H-7′), 4.94 (d, 1H,
J1″,2″ 7.7 Hz, H-1″), 4.90 (d, 1H, J 11.5 Hz, CHHPh), 4.89 (d, 1H, J 11.3 Hz,
CHHPh), 4.83–4.74 (m, 4H, 2× CHHPh, H-7, H-8a), 4.62 (dd, 1H, J8′a,8′b
12.5 Hz, H-8′a), 4.44 (app t, 1H, J8b,8a ~ J8b,7 8.1 Hz, H-8b), 4.37 (dd,
1H, J6″a,6″b 10.4, J6″a,5″ 5.0 Hz, H-6″a), 4.29 (ddd, 1H, J4,3ax 11.7, J4,3eq 5.2,
J4,5 2.7 Hz, H-4), 4.11–4.09 (m, 1H, H-5), 4.04–4.00 (m, 2H, H-6′,
H-8′b), 3.96–3.94 (m, 1H, H-6), 3.85 (s, 3H, CO2CH3), 3.81 (app t, 1H,
J3″,2″ ~ J3″,4″ 8.9 Hz, H-3″), 3.74 (s, 3H, CO2CH3), 3.74 (app t, 1H, J6″b,5″
10.4 Hz, H-6″b), 3.60 (app t, 1H, J4″,5″ 9.2 Hz, H-4″), 3.46 (app dt, 1H,
H-5″), 3.31 (app t, 1H, H-2″), 3.24 (s, 3H, OCH3), 2.23–2.19 (m, 1H,
H-3′eq), 2.16 (app t, 1H, J3ax,3eq ~ 12.2 Hz, H-3ax), 2.10–2.04 (m, 8H,
2× COCH3, H-3eq, H-3′ax), 2.00 and 1.98 (2 s, each 3H, COCH3); 13C
NMR (CDCl3): δ 170.93, 170.23, 169.64 and 169.57 (4 s, 4C, COCH3),
168.18 and 167.52 (2 s, 2C, C-1, C-1′), 154.64 [s, OC(=O)O], 138.47,
138.03 and 137.13 (3 s, 3C, Ar), 129.02, 128.36, 128.25, 127.91, 127.76,
127.69, 127.58 and 125.96 (8 d, 15C, Ar), 102.92 (d, C-1″), 101.22
(d, PhCH), 99.16 and 99.04 (2 s, 2C, C-2, C-2′), 81.67 (d, C-4″), 81.32
(d, C-2″), 80.72 (d, C-3″), 76.72 (d, C-7), 75.14 (t, CH2Ph), 74.50 (t,
CH2Ph), 71.06 (d, C-6), 69.97 (d, C-5), 69.78 (d, C-6′), 68.88 (d, C-4),
68.67 (t, C-6″), 67.76 (d, C-7′), 66.11 (d, C-4′), 65.95 (d, C-5″), 65.51
(t, C-8), 64.23 (d, C-5′), 61.86 (t, C-8′), 53.16 and 52.68 (2 q, 2C,
CO2CH3), 51.32 (q, OCH3), 34.12 (t, C-3), 32.40 (t, C-3′), 20.78, 20.64
and 20.62 (3 q, 4C, COCH3); ESI-TOF HRMS: m/z = 1142.4088; calcd
for C55H64O25NH4+: 1142.4075.
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3.5. Sodium (3-deoxy-α-D-manno-oct-2-ulopyranosyl)onate-
(2→4)-[α-D-glucopyranosyl-(1→5)]-sodium (methyl
3-deoxy-α-D-manno-oct-2-ulopyranosid)onate (10)
Trisaccharide 9α (11.3 mg, 0.010 mmol) was dissolved in dry
MeOH (1.0 mL); the atmosphere was exchanged to argon and 10%
Pd-C (1 mg) was added. The atmosphere was exchanged succes-
sively to argon and hydrogen (1 atm). After 4 h, the catalyst was
ﬁltered off, rinsed with MeOH and the ﬁltrate was concentrated. The
residue was dried and then dissolved in anhydrous MeOH (1.0 mL)
and treated with sodium methoxide (0.1 M in MeOH, 60 μL,
0.006mmol) for 17 h at rt. Ion exchange resin DOWEX 50 (H+ form)
was added until the solution reacted neutral. The resin was ﬁl-
tered off immediately, rinsed with MeOH and the ﬁltrate was
concentrated. A solution of the residue in H2O (1.0 mL) was treated
with aq NaOH (0.1 M, 1.0 mL) at 0 °C for 4 h at ambient tempera-
ture. The mixture was made neutral by adding DOWEX 50 resin (H+-
form). Filtration of the resin and freeze-drying of the ﬁltrate afforded
a salt-containing product, which was desalted on a PD10 SEC column
(H2O). Lyophilisation of the pooled fractions yielded trisaccharide
10 (6.4 mg, 94%) as a colorless amorphous solid: [α]D20 + 114.9 (c
0.59, H2O); 1H NMR (D2O, pD ~ 7.4): δ 5.24 (d, 1H, J1″,2″ 3.6 Hz, H-1″),
4.19–4.17 (m, 1H, H-5), 4.08–4.03 (m, 2H, H-5″, H-7), 3.97–3.91 (m,
3H, H-4, H-5′, H-7′), 3.91 (ddd, 1H, J4′,5′ 3.0 Hz, H-4′), 3.89–3.86 (m,
2H, H-8a, H-8′a), 3.85 (dd, 1H, J6″a,6″b 12.2, J6″a,5″ 2.6 Hz, H-6″), 3.78
(app t, 1H, J3″,4″ 9.2 Hz, H-3″), 3.665 (br d, 1H, J6′,7′ 7.5 Hz, H-6′), 3.66
(dd, 1H, J8′a,8′b 11.8, J7′,8′b 7.2 Hz, H-8′b), 3.58 (dd, 1H, J8b,8a 11.8, J8b,7
6.5 Hz, H-8b), 3.51 (app t, 1H, J5″,4″ 9.7 Hz, H-4″), 3.50 (br d, 1H, J6,7
9.5 Hz, H-6), 3.46 (dd, 1H, J2″,3″ 9.9 Hz, H-2″), 3.07 (s, 3H, OCH3), 2.05
(dd, 1H, J3′eq,3′ax 13.2, J3′eq,4′ 4.7 Hz, H-3′eq), 2.01 (dd, 1H, J3eq,3ax
12.6, J3eq,4 4.8 Hz, H-3eq), 1.94 (app t, 1H, J3ax,4 12.3 Hz, H-3ax),
1.75 (app t, 1H, J3′ax,4′ 12.7 Hz, H-3′ax); 13C NMR (D2O, pD ~ 7.4): see
Table 1; ESI-TOF HRMS: m/z = 657.1838; calcd for C23H38O20Na+:
657.1849.
3.6. Methyl (4,5,7,8-tetra-O-acetyl-3-deoxy-α-D-manno-oct-2-
ulopyranosyl)onate-(2→4)-[2,3,6-tri-O-benzyl-α-D-glucopyranosyl-
(1→5)]-methyl (methyl 7,8-O-carbonyl-3-deoxy-α-D-manno-oct-2-
ulopyranosid)onate (11), methyl (4,5,7,8-tetra-O-acetyl-3-deoxy-
α-D-manno-oct-2-ulopyranosyl)onate-(2→4)-[2,3,4-tri-O-benzyl-α-
D-glucopyranosyl-(1→5)]-methyl (methyl 7,8-O-carbonyl-3-deoxy-
α-D-manno-oct-2-ulopyranosid)onate (12) and methyl (4,5,7,8-
tetra-O-acetyl-3-deoxy-α-D-manno-oct-2-ulopyranosyl)onate-
(2→4)-[2,3-di-O-benzyl-α-D-glucopyranosyl-(1→5)]-methyl (methyl
7,8-O-carbonyl-3-deoxy-α-D-manno-oct-2-ulopyranosid)onate (13)
A cooled (0 °C) solution of compound 9α (188 mg, 0.167 mmol)
in dry CH2Cl2 (6.0 mL) was treated with triethylsilane (400 μL,
2.506 mmol) and BF3·Et2O (41 μL, 0.334 mmol) successively. After
1 h at 0 °C the mixture was diluted with CH2Cl2 and washed with
aq. NaHCO3. The aqueous phasewas once again extractedwith CH2Cl2
and the combined organic phases were washed with water, dried
(MgSO4) and concentrated. The residue was puriﬁed on an HPLC
column (n-hexane/EtOAc 3:2 → 1:2) providing some recovered start-
ingmaterial 9α (7mg, 3%), the desired 6-OBn compound 11 (135mg,
72%), the 4-OBn isomer 12 (10 mg, 5%) and the diol 13 (3 mg, 2%)
successively. Data for 11: colorless oil; [α]D20 + 102.6 (c 1.12, CHCl3);
Rf 0.38 (n-hexane/EtOAc 1:1, HP-TLC); 1H NMR (CDCl3): δ 7.41–
7.27 (m, 15H, Ar), 5.34–5.33 (m, 1H, H-5′), 5.23 (ddd, 1H, J4′,3′ax 12.6,
J4′,3′eq 5.0, J4′,5′ 2.8 Hz, H-4′), 5.20 (ddd, 1H, J7′,6′ 9.4, J7′,8′b 4.4, J7′,8′a 2.8 Hz,
H-7′), 5.10 (d, 1H, J1″,2″ 3.6 Hz, H-1″), 4.97 (d, 1H, J 11.4 Hz, CHHPh),
4.87 (d, 1H, J 11.4 Hz, CHHPh), 4.82 (d, 1H, J 10.8 Hz, CHHPh), 4.77–
4.73 (m, 1H, H-7), 4.62 (dd, 1H, J8′a,8′b 12.1, J8′a,7′ 2.6 Hz, H-8′a), 4.59
(d, 1H, J 10.8 Hz, CHHPh), 4.55 (d, 1H, J 11.5 Hz, CHHPh), 4.48 (d,
1H, J 11.5 Hz, CHHPh), 4.49–4.46 (m, 1H, H-8a), 4.22–4.18 (m, 2H,
H-4, H-8b), 4.10 (dd, 1H, J6′,5′ 1.7 Hz, H-6′), 4.06 (dd, 1H, H-8′b), 3.86–
3.85 (m, 1H, H-5), 3.84–3.81 (m, 4H, H-5″, CO2CH3), 3.80 (s, 3H,
CO2CH3), 3.76 (dd, 1H, J6″a,6″b 10.1, J6″a,5″ 3.8 Hz, H-6″a), 3.74–3.67 (m,
3H, H-3″, H-4″, H-6), 3.58 (dd, 1H, J6″b,5″ 4.5 Hz, H-6″b), 3.53 (dd, 1H,
J2″,3″ 9.2 Hz, H-2″), 3.18 (s, 3H, OCH3), 2.62 (d, 1H, JOH,4″ 2.2 Hz, OH),
2.24–2.20 (m, 1H, H-3′eq), 2.12 (app t, 1H, J3ax,3eq ~ J3ax,4 12.2 Hz,
H-3ax), 2.09 and 2.08 (2 s, each 3H, COCH3), 2.09–2.01 (m, 2H, H-3′ax,
H-3eq), 1.99 and 1.91 (2 s, each 3H, COCH3); 13C NMR (CDCl3): δ
170.93, 170.30, 169.71 and 169.63 (4 s, 4C, COCH3), 168.36 and 167.46
(2 s, 2C, C-1, C-1′), 154.49 [s, O(C=O)O], 138.50, 137.90 and 137.74
(3 s, 3C, Ar), 128.65, 128.58, 128.41, 128.24, 128.00, 127.95, 127.92,
127.76 and 127.62 (9 d, 15C, Ar), 99.76 (d, C-1″), 99.12 and 99.04
(2 s, 2C, C-2, C-2′), 80.95 (d, C-3″), 80.12 (d, C-2″), 75.79 (d, C-5),
75.14 (t, CH2Ph), 74.97 (d, C-7), 74.15 (t, CH2Ph), 73.45 (t, CH2Ph),
72.22 (d, 2C, C-4″, C-6), 70.70 (d, C-5″), 70.10 (t, C-6″), 69.62 (d, C-6′),
68.70 (d, C-4), 67.82 (d, C-7′), 66.21 (t, C-8), 66.06 (d, C-4′), 64.29
(d, C-5′), 61.94 (t, C-8′), 53.12 (q, CO2CH3), 52.64 (q, CO2CH3), 51.20
(q, OCH3), 34.18 (t, C-3), 31.96 (t, C-3′), 20.69, 20.62 and 20.59 (3
q, 4C, COCH3); ESI-TOF HRMS: m/z = 1144.4239; calcd for
C55H66O25NH4+: 1144.4231.
12: colorless oil; [α]D20 + 110.8 (c 0.89, CHCl3); Rf 0.30 (n-hexane/
EtOAc 1:1, HP-TLC); 1H NMR (CDCl3): δ 7.41–7.27 (m, 15H, Ar), 5.36–
5.32 (m, 2H, H-4′, H-5′), 5.19 (ddd, 1H, J7′,6′ 9.4, J7′,8′b 4.1, J7′,8′a 2.8 Hz,
H-7′), 5.09 (d, 1H, J1″,2″ 3.6 Hz, H-1″), 4.97 (d, 1H, J 11.2 Hz, CHHPh),
4.94 (d, 1H, J 11.2 Hz, CHHPh), 4.88 (d, 1H, J 10.7 Hz, CHHPh), 4.83
(d, 1H, J 10.8 Hz, CHHPh), 4.72 (d, 1H, J 10.6 Hz, CHHPh), 4.66 (dd,
1H, J8′a,8′b 12.3 Hz, H-8′a), 4.61–4.54 (m, 3H, H-7, H-8a, CHHPh), 4.32
(app t, 1H, J8b, 8a ~ J8b,7 7.6 Hz, H-8b), 4.18 (dd, 1H, J6′,5′ 1.3 Hz, H-6′),
4.12 (ddd, 1H, J4,3ax 12.0, J4,3eq 4.6, J4,5 2.5 Hz, H-4), 4.02 (dd, 1H, H-8′b),
3.86 (s, 3H, CO2CH3), 3.86–3.84 (m, 1H, H-5), 3.83–3.79 (m, 3H, H-3″,
H-6″a, H-6″b), 3.78 (s, 3H, CO2CH3), 3.75–3.72 (m, 2H, H-5″, H-6),
3.67 (dd, 1H, J 9.8, J 9.1 Hz, H-4″), 3.54 (dd, 1H, J2″,3″ 9.6 Hz, H-2″),
3.16 (s, 3H, OCH3), 2.90 (app t, 1H, J 6.6 Hz, OH), 2.28–2.24 (m, 1H,
H-3′eq), 2.16 -2.12 (m, 1H, H-3eq), 2.08 and 2.06 (2 s, each 3H, COCH3),
2.07–2.01 (m, 2H, H-3ax, H-3′ax), 2.00 and 1.99 (2 s, each 3H, COCH3);
13C NMR (CDCl3): δ 170.79, 170.52, 170.16 and 169.68 (4 s, 4C,
COCH3), 168.27 and 167.44 (2 s, 2C, C-1, C-1′), 154.65 [s, O(C = O)O],
138.40, 137.91 and 137.70 (3 s, 3C, Ar), 128.70, 128.56, 128.51, 128.38,
128.19, 128.13, 127.99 and 127.83 (8 d, 15C, Ar), 99.89 (d, C-1″), 99.67
and 98.93 (2 s, 2C, C-2, C-2′), 81.50 (d, C-3″), 80.56 (d, C-2″), 77.72
(d, C-4″), 76.15 (d, C-5), 75.93 (d, C-7), 75.38 (t, CH2Ph), 75.35 (t,
CH2Ph), 74.47 (t, CH2Ph), 72.57 (d, C-5″), 71.84 (d, C-6), 70.05 (d, C-4),
69.65 (d, C-6′), 67.80 (d, C-7′), 66.41 (d, C-4′), 65.88 (t, C-8), 64.36
(d, C-5′), 61.63 (t, C-8′), 61.07 (t, C-6″), 53.17 (q, CO2CH3), 52.67 (q,
CO2CH3), 51.20 (q, OCH3), 33.81 and 32.53 (2 t, 2C, C-3, C-3′), 20.86,
20.63 and 20.59 (3 q, 4C, COCH3); ESI-TOF HRMS: m/z = 1149.3771;
calcd for C55H66O25Na+: 1149.3785.
13: colorless oil; Rf 0.06 (n-hexane/EtOAc 1:1); 1H NMR (CDCl3):
δ 7.40–7.31 (m, 10H, Ar), 5.35–5.33 (m, 1H, H-5′), 5.31 (ddd, 1H, J4′,3′ax
12.1, J4′,3′eq 4.7, J4′,5′ 3.0 Hz, H-4′), 5.20 (ddd, 1H, J7′,6′ 9.4, J7′,8′b 4.2, J7′,8′a
2.8 Hz, H-7′), 5.13 (d, 1H, J1″,2″ 3.5 Hz, H-1″), 5.02 (d, 1H, J 11.5 Hz,
CHHPh), 4.83 (d, 2H, J 11.3 Hz, CHHPh, CHHPh), 4.68 (ddd, 1H, J7,8b
8.3, J7,8a 5.7, J7,6 3.9 Hz, H-7), 4.65 (dd, 1H, J8′a,8′b 12.4 Hz, H-8′a), 4.60
(d, 1H, J 10.9 Hz, CHHPh), 4.57 (dd, 1H, J8a,8b 8.4 Hz, H-8a), 4.32 (app
t, 1H, H-8b), 4.18–4.14 (m, 2H, H-4, H-6′), 4.04 (dd, 1H, H-8′b), 3.88–
3.87 (m, 1H, H-5), 3.86 (s, 3H, CO2CH3), 3.80 (s, 3H, CO2CH3), 3.79–
3.76 (m, 2H, H-6″a, H-6″b), 3.75–3.66 (m, 4H, H-3″, H-4″, H-5″, H-6),
3.56–3.51 (m, 1H, H-2″), 3.18 (s, 3H, OCH3), 2.85 (b s, 1H, OH), 2.44
(b s, 1H, OH), 2.27 (dd, 1H, J3′eq,3′ax 12.7 Hz, H-3′eq), 2.14–2.10 (m,
2H, H-3ax, H-3eq), 2.083 and 2.077 (2 s, each 3H, COCH3), 2.05 (app
t, 1H, H-3′ax), 2.00 and 1.98 (2 s, each 3H, COCH3); 13C NMR (CDCl3):
δ 170.83, 170.53, 170.15 and 169.68 (4 s, 4C, COCH3), 168.30 and
167.46 (2s, 2C, C-1, C-1′), 154.54 [s, O(C = O)O], 138.41 and 137.62
(2s, 2C, Ar), 128.73, 128.69, 128.39, 128.06, 128.03 and 127.81 (6
d, 10C, Ar), 99.71 (d, C-1″), 99.54 and 99.02 (2 s, 2C, C-2, C-2′), 81.21
(d, C-3″), 80.43 (d, C-2″), 75.85 (d, C-5), 75.41 (d, C-7), 75.12 (t,
CH2Ph), 74.17 (t, CH2Ph), 72.41 (d, C-5″), 72.03 (d, C-6), 70.50 (d, C-4″),
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69.76 and 69.66 (2 d, 2C, C-4, C-6′), 67.77 (d, C-7′), 66.40 (d, C-4′),
66.09 (t, C-8), 64.34 (d, C-5′), 61.88 (t, C-6″), 61.74 (t, C-8′), 53.20
(q, CO2CH3), 52.69 (q, CO2CH3), 51.24 (q, OCH3), 33.94 (t, C-3), 32.40
(t, C-3′), 20.86, 20.64 and 20.59 (3 q, 4C, COCH3); ESI-TOF HRMS:
m/z = 1059.3303; calcd for C48H60O25Na+: 1059.3316.
3.7. Methyl (4,5,7,8-tetra-O-acetyl-3-deoxy-α-D-manno-oct-2-
ulopyranosyl)onate-(2→4)-[2,3,4,6-tetra-O-acetyl-β-D-
glucopyranosyl-(1→4)-2,3,6-tri-O-benzyl-α-D-glucopyranosyl-
(1→5)]-methyl (methyl 7,8-O-carbonyl-3-deoxy-α-D-manno-oct-2-
ulopyranosid)onate (15)
A solution of acceptor 11 (24.8 mg, 0.022 mmol) and donor 1421
(22.9 mg, 0.044 mmol) in dry CH2Cl2 (1.0 mL) containing 5 Å mo-
lecular sieves (50 mg) was stirred at ambient temperature for 1 h.
The cooled (0 °C) mixture was treated with TfOH (0.10 μL, 1.1 μmol)
in dry CH2Cl2 (20 μL) and stirred for 15 min at 0 °C. The promoter
was neutralized with triethylamine (15 μL, 0.110 mmol), the sus-
pension was ﬁltered over Celite®, rinsed with CH2Cl2 and the ﬁltrate
was concentrated. The residue was subjected to HP-chromatography
(toluene/EtOAc 2:1 → 1:2) affording impure product fractions, which
were further puriﬁed by HPLC (n-hexane/EtOAc 2:1 → 1:2) to obtain
pure 15 (14.7mg, 46%) as a colorless oil: [α]D20 + 93.5 (c 0.50, CHCl3);
Rf 0.30 (toluene/EtOAc 1:1, HP-TLC); 1H NMR (CDCl3): δ 7.44–7.18
(m, 15H, Ar), 5.36–5.34 (m, 1H, H-5′), 5.26 (ddd, 1H, J4′,3′ax 12.5, J4′,3′eq
5.0, J4′,5′ 2.9 Hz, H-4′), 5.21 (ddd, 1H, J7′,6′ 9.2, J7′,8′b 4.1, J7′,8′a 2.7 Hz,
H-7′), 5.07 (d, 1H, J1″,2″ 3.8 Hz, H-1″), 5.05 (d, 1H, J 11.5 Hz, CHHPh),
5.01 (app t, 1H, J4‴,3‴ ~ J4‴,5‴ 9.5 Hz, H-4‴), 4.94 (app. t, 1H, J3‴,2‴ 9.2 Hz,
H-3‴), 4.92–4.89 (m, 1H, H-2‴), 4.75–4.71 (m, 3H, 2× CHHPh, CHHPh),
4.68 (app td, 1H, J7,8b 8.1, J7,6 ~ J7,8a 5.0 Hz, H-7), 4.61 (dd, 1H, J8′a,8′b
12.4 Hz, H-8′a), 4.50 (d, 1H, J 10.9 Hz, CHHPh), 4.48 (d, 1H, J1‴,2‴ 7.7 Hz,
H-1‴), 4.45 (dd, 1H, J8a,8b 8.5, J8a,7 5.5 Hz, H-8a), 4.31 (d, 1H, J 11.6 Hz,
CHHPh), 4.20 (ddd, 1H, J 9.7, J 7.0, J4,5 2.5 Hz, H-4), 4.14 (dd, 1H, J6″a,5″
4.3, J6″a,6″b 12.5 Hz, H-6″a), 4.12 (br, d, 1H, J6′,7′ 9.2 Hz, H-6′), 4.11 (app
t, 1H, H-8b), 4.07 (dd, 1H, H-8′b), 3.94 (app t, 1H, J4″,3″ ~ J4″,5″ 9.5 Hz,
H-4″), 3.90 (dd, 1H, J6‴b,6‴a 12.2, J6‴,5‴ 2.3 Hz, H-6‴b), 3.85–3.84 (m,
1H, H-5), 3.82 (s, 3H, CO2CH3), 3.81 (dd, 1H, J6″a,6″b 10.5, J6″a,5″ 2.5 Hz,
H-6″a), 3.81 (s, 3H, CO2CH3), 3.68 (app t, 1H, H-3″), 3.67–3.65 (m,
2H, H-5″, H-6), 3.53 (dd, 1H, J6″b,5″ 1.1 Hz, H-6″b), 3.48 (dd, 1H, J2″,3″
9.8 Hz, H-2″), 3.29 (ddd, 1H, J5‴,6‴a 4.2 Hz, H-5‴), 3.19 (s, 3H, OCH3),
2.25 (dd, 1H, J3′eq,3′ax 13.0 Hz, H-3′eq), 2.10 (app t, 1H, H-3′ax), 2.095
and 2.08 (2 s, each 3H, COCH3), 2.04–2.01 (m, 2 H, H-3ax, H-3eq),
2.01, 1.99, 1.98, 1.97, 1.94 and 1.90 (6 s, each 3H, COCH3); 13C NMR
(CDCl3): δ 170.92, 170.59, 170.33, 170.16, 169.91, 169.62, 169.34 and
169.10 (8 s, 8C, COCH3), 168.36 and 167.56 (2 s, 2C, C-1, C-1′), 154.57
[s, O(C = O)O], 139.00, 137.81 and 137.76 (3 s, 3C, Ar), 128.73, 128.54,
128.31, 128.23, 128.18, 127.56 and 127.48 (7 d, 15C, Ar), 100.10 (d,
C-1″), 99.97 (d, C-1‴), 99.07 and 98.97 (2 s, 2C, C-2, C-2′), 79.68 (d,
C-2″), 79.62 (d, C-3″), 77.0 (d, C-4″, overlapped by solvent peak), 76.16
(d, C-5), 75.06 (d, C-7), 75.03 (t, CH2Ph), 74.52 (t, CH2Ph), 73.49 (t,
CH2Ph), 73.19 (d, C-3‴), 72.26 (d, C-6), 71.90 (d, C-2‴), 71.46 (d, C-5‴),
71.35 (d, C-5″), 69.66 (d, C-6′), 68.55 (d, C-4), 68.21 (d, C-4‴), 67.85
(d, C-7′), 67.75 (t, C-6″), 66.06 (t, C-8), 66.03 (d, C-4′), 64.25 (d, C-5′),
61.92 (t, C-8′), 61.66 (t, C-6‴), 53.17 and 52.65 (2 q, 2C, CO2CH3), 51.22
(q, OCH3), 34.28 (t, C-3), 31.91 (t, C-3′), 20.72, 20.63, 20.59 and 20.56
(4 q, 8C, COCH3); ESI-TOF HRMS: m/z = 1479.4740; calcd for
C69H84O34Na+: 1479.4736.
3.8. Sodium (3-deoxy-α-D-manno-oct-2-ulopyranosyl)onate-
(2→4)-[β-D-glucopyranosyl-(1→4)-α-D-glucopyranosyl-(1→5)]-
sodium (methyl 3-deoxy-α-D-manno-oct-2-ulopyranosid)onate (16)
According to the procedure for compound 10, tetrasaccharide
15 (14.0 mg, 0.010 mmol) was debenzylated in dry MeOH (1.0 mL)
over 10% Pd-C (1 mg) under hydrogen at atmospheric pressure for
3 h at rt, and deacetylated by treatment with sodium methoxide
(0.1 M in MeOH, 24 μL, 2.4 μmol) in dry MeOH (1.0 mL) for 14 h at
rt. A solution of the deblocked intermediate in H2O (2 mL) and aq
NaOH (0.1 M, 0.5 mL) was stirred for 2 h at 0 °C and for 1 h at
ambient temperature followed by neutralization with Dowex resin
and processing as described for 10. The ﬁltrate was lyophilized
and the residue was desalted on a PD10 SEC column (H2O) to give
16 (8.0 mg, 99%) as a colorless amorphous solid: [α]D20 + 91.4 (c
0.56, H2O); 1H NMR (D2O, pD ~ 7.4): δ 5.25 (d, 1H, J1″,2″ 3.5 Hz,
H-1″), 4.49 (d, 1H, J1‴,2‴ 7.7 Hz, H-1‴), 4.25–4.20 (m, 2H, H-5, H-5″),
4.03 (ddd, 1H, J7,6 9.4, J7,8b 6.4, J7,8a 2.9 Hz, H-7), 3.97–3.84 (m, 10H,
H-3″, H-4, H-4′, H-5′, H-6″a, H-6″b, H-6‴a, H-7′, H-8a, H-8′a), 3.71
(app t, 1H, J4″,3″ ~ J4″,5″ 9.7 Hz, H-4″), 3.70 (dd, 1H, J6‴b,6‴a 12.1, J6‴b,5‴
6.1 Hz, H-6‴b), 3.67 (d, 1H, J6′,7′ 8.2 Hz, H-6′), 3.66 (dd, 1H, J8′b,8′a
11.6, J8′b,7′ 7.3 Hz, H-8′b), 3.59 (dd, 1H, J8b,8a 11.9, H-8b), 3.52 (dd,
1H, J2″,3″ 10.3 Hz, H-2″), 3.51 (d, J6,7 10.3 Hz, H-6), 3.49–3.44 (m,
2H, H-3‴, H-5‴), 3.38 (app t, 1H, J4‴,3‴ ~ J4‴,5‴ 9.5 Hz, H-4‴), 3.28
(dd, 1H, J2‴,3‴ 9.3 Hz, H-2‴), 3.08 (s, 3H, OCH3), 2.07–1.99 (m, 2H,
H-3eq, H-3′eq), 1.95 (app t, 1H, J3ax,3eq ~ J3ax,4 12.3 Hz, H-3ax), 1.76
(app t, J3′ax,3′eq ~ J3′ax,4′ 12.5 Hz, H-3′ax); 13C NMR (D2O, pD ~ 7.4):
see Table 1; ESI-TOF HRMS: m/z = 819.2375; calcd for C29H48O25Na+:
819.2377.
3.9. 2,3,4,6-Tetra-O-acetyl-α-D-glucopyranosyl-(1→6)-2,3,4-tri-O-
acetyl-α,β-D-glucopyranosyl (N-phenyl)triﬂuoroacetimidate (17)
A solution of isomaltose (100 mg, 0.292 mmol) in dry pyridine
(2.0 mL) was treated with acetic anhydride (0.8 mL) and 4-(N,N-
dimethylamino)pyridine (5 mg) at 0 °C and after 20 h at ambient
temperature, excessive reagent was destroyed by adding dry MeOH
(2.0 mL) at 0 °C. After 10 min the solvent was coevaporated with
toluene (3×) and the residual oil was puriﬁed by chromatography
(n-hexane/EtOAc 1:1 → 1:2) affording an α/β-mixture (1:1) of
peracetylated isomaltose (198 mg, quantitative yield). The residue
(101mg, 0.149mmol) was dissolved in dry DMF (2.0mL) and treated
with hydrazine acetate (27 mg, 0.298 mmol) at 40 °C for 2 h under
Ar. The mixture was diluted with EtOAc, washed with cold brine
and the organic layer was dried (MgSO4) and ﬁltered. Concentra-
tion of the ﬁltrate provided a crude product, which was puriﬁed
by chromatography (n-hexane/EtOAc 1:2) to obtain an α/β-
mixture (1:0.3) of the hemiacetal (85 mg, 90%): 1H NMR (CDCl3): δ
5.53 (dd, 1H, J3α,2α 10.1, J3α,4α 9.4 Hz, H-3α), 5.46 (app t, 1H, J3′β,2′β ~ J3′β,4′β
9.8 Hz, H-3′β), 5.45 (app t, 1H, J3′α,2′α ~ J3′α,4′α 9.8 Hz, H-3′α), 5.40
(app t, 1H, J1α,2α ~ J1α,OH 3.5 Hz, H-1α), 5.23 (app t, 1H, J3β,2β ~ J3β,4β
Hz, H-3β), 5.14 (d, 1H, J1′β,2′β 3.8 Hz, H-1′β), 5.13 (d, 1H, J1′α,2′α
3.8 Hz, H-1′α), 5.02–4.97 (m, 3H, H-4′α, H-4β, H-4α), 4.94 (dd, 1H,
J4α,5α 10.3 Hz, H-4α), 4.85–4.78 (m, 4H, H-2α, H-2′α, H-2β, H-2′β),
4.73 (app t, 1H, J 8.0 Hz, H-1β), 4.24 (ddd, 1H, J5α,6aα 6.5, J5α,6bα
2.5 Hz, H-5α), 4.21–4.05 (m, 7H, H-5′α, H-5′β, H-6′aα, H-6′aβ,
H-6′bα, H-6′bβ, OHβ), 4.02–3.99 (m, 1H, OHα), 3.74–3.57 (m,
5H, H-5β, H-6aα, H-6aβ, H-6bα, H-6bβ), 2.10 to 2.00 (10 s, 14×
COCH3); ESI-TOF HRMS: m/z = 659.1794; calcd for C26H36O18Na+:
659.1798.
The residue (70 mg, 0.110 mmol) was dissolved in dry CH2Cl2
(1.8 mL) and dry acetone (1.0 mL). Potassium carbonate (30 mg,
0.220mmol) and 2,2,2-triﬂuoro-N-phenylacetimidoyl chloride (35 μL,
0.220mmol) were added successively under Ar. The suspension was
stirred for 12 h at rt, then ﬁltered through a pad of Celite, rinsed
with CH2Cl2 and the ﬁltrate was concentrated. Swift chromato-
graphic puriﬁcation (n-hexane/EtOAc 1:1) provided 17 (80mg, 90%)
which was directly used for the subsequent glycosylation reac-
tion. 1H NMR spectra of 17 (CDCl3) displayed broad signals
corresponding to a 2.5:1 mixture; 13C NMR (125 MHz, CDCl3, se-
lected data): δ 169.8-168.9 (C = O, Ac), 142.8, 128.9, 128.8 124.7 and
119.4 (arom. C), 96.0 (C-1, C-1′), 66.4 and 66.2 (C-6), 61.7 (C-6′), 20.6-
20.4 (CH3CO).
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3.10. Methyl (4,5,7,8-tetra-O-acetyl-3-deoxy-α-D-manno-oct-2-
ulopyranosyl)onate-(2→4)-[2,3,4,6-tetra-O-acetyl-α-D-
glucopyranosyl-(1→6)-2,3,4-tri-O-acetyl-β-D-glucopyranosyl-
(1→4)-2,3,6-tri-O-benzyl-α-D-glucopyranosyl-(1→5)]-methyl
(methyl 7,8-O-carbonyl-3-deoxy-α-D-manno-oct-2-
ulopyranosid)onate (18)
A suspension of acceptor 11 (20.0 mg, 0.018 mmol) and donor
17 (28.7 mg, 0.035mmol) in dry CH2Cl2 (1.0 mL) containing 5 Å mo-
lecular sieves (50 mg) was stirred at ambient temperature for 1 h.
The cooled (0 °C) mixture was treatedwith TfOH (0.04 μL, 0.44 μmol)
in dry CH2Cl2 (10 μL) and stirred for 30 min at 0 °C. An additional
portion of TfOH (0.16 μL, 1.76 μmol) was added (0 °C) and after
15min triethylamine (12.3 μL, 0.089mmol) was added. The mixture
was ﬁltered over Celite, rinsed with CH2Cl2 and the ﬁltrate was con-
centrated. The residue was subjected to HP-chromatography
(toluene/EtOAc 2:1 → 1:2) affording impure product fractions which
were further puriﬁed by HPLC (n-hexane/EtOAc 1:1 → 1:2) to give
pure 18 (22.0mg, 71%) as a colorless oil: [α]D20 + 105.8 (c 1.10, CHCl3);
Rf 0.16 (n-hexane/EtOAc 1:1, HP-TLC); 1H NMR (CDCl3): δ 7.44–
7.25 (m, 15H, Ar), 5.38 (app t, 1H, J3″″,2″″ ~ J3″″,4″″ 9.7 Hz, H-3″″), 5.34–
5.33 (m, 1H, H-5′), 5.24 (ddd, 1H, J4′,3′ax 12.6, J4′,3′eq 4.9, J4′,5′ 2.9 Hz,
H-4′), 5.20 (ddd, 1H, J7′,6′ 9.3, J7′,8′b 4.3, J7′,8′a 2.8 Hz, H-7′), 5.03 (d, 1H,
J1″,2″ 3.9 Hz, H-1″), 5.02 (app t, 1H, J4″″,5″″ 9.7 Hz, H-4″″), 5.00 (app t,
1H, J3‴,2‴ ~ J3‴,4‴ 9.3 Hz, H-3‴), 4.98 (d, 1H, J1″″,2″″ 3.4 Hz, H-1″″), 4.92
(app t, 1H, J4‴,5‴ 9.5 Hz, H-4‴), 4.90–4.87 (m, 2H, H-2‴, CHHPh), 4.83–
4.80 (m, 2H, H-2″″, CHHPh), 4.79 (d, 1H, J 11.7 Hz, CHHPh), 4.69 (d,
1H, J 11.7 Hz, CHHPh), 4.67 (ddd, 1H, J7,8b 8.3, J7,8a 5.4, J7,6 4.6 Hz, H-7),
4.60 (dd, 1H, J8′a,8′b 12.3 Hz, H-8′a), 4.55 (d, 1H, J 11.0 Hz, CHHPh),
4.51 (d, 1H, J1‴,2‴ 8.0 Hz, H-1‴), 4.42 (dd, 1H, J8a,8b 8.6 Hz, H-8a), 4.29
(d, 1H, J 11.8 Hz, CHHPh), 4.21 (dd, 1H, J6″″a,6″″b 12.3, J6″″a,5″″ 4.0 Hz,
H-6″″a), 4.19 (ddd, 1H, J4,3ax 11.3, J4,3eq 5.5, J4,5 2.5 Hz, H-4), 4.11 (dd,
1H, J6′,5′ 1.4 Hz, H-6′), 4.08–4.04 (m, 2H, H-8b, H-8′b), 3.96 (dd, 1H,
J6″″b,5″″ 2.3 Hz, H-6″″b), 3.94 (app t, 1H, J4″,3″ ~ J4″,5″ 9.5 Hz, H-4″), 3.88
(ddd, 1H, H-5″″), 3.84–3.83 (m, 1H, H-5), 3.82 (s, 3H, CO2CH3), 3.80
(s, 3H, CO2CH3), 3.78 (dd, 1H, J6″a,6″b 10.8, J6″a,5″ 2.8 Hz, H-6″a), 3.67–
3.63 (m, 3H, H-3″, H-5″, H-6), 3.49 (dd, 1H, J6″b,5″ 1.5 Hz, H-6″b), 3.46
(dd, 1H, J2″,3″ 9.7, H-2″), 3.42 (dd, 1H, J6‴a,6‴b 11.6, J6‴a,5‴ 5.4 Hz, H-6‴a),
3.35 (dd, 1H, J6‴b,5‴ 4.2 Hz, H-6‴b), 3.30–3.26 (m, 1H, H-5‴), 3.18 (s,
3H, OCH3), 2.22–2.18 (m, 1H, H-3′eq), 2.11 (app t, 1H, J3′ax,3′eq 13.1 Hz,
H-3′ax), 2.07–1.99 (m, 2H, H-3eq, H-3ax), 2.09, 2.08, 2.06, 2.02, 2.01,
2.00, 1.99, 1.98, 1.96 and 1.89 (10 s, 33H, COCH3); 13C NMR (CDCl3):
δ 170.89, 170.48, 170.31, 170.14, 169.94, 169.91, 169.90, 169.60,
169.50, 169.45 and 169.16 (11 s, 11C, COCH3), 168.38 and 167.55
(2 s, 2C, C-1, C-1′), 154.58 [s, O(C = O)O], 138.81, 137.86 and 137.83
(3 s, 3C, Ar), 128.71, 128.60, 128.33, 128.24, 128.19, 128.14, 127.99
and 127.53 (8 d, 15C, Ar), 100.15 (d, C-1″), 99.76 (d, C-1‴), 99.09 and
98.95 (2 s, 2C, C-2, C-2′), 96.12 (d, C-1″″), 79.71 (d, C-2″), 79.33 (d,
C-3″), 76.88 (d, C-4″), 76.07 (d, C-5), 75.09 (d, C-7), 75.01 (t, CH2Ph),
74.58 (t, CH2Ph), 73.53 (t, CH2Ph), 73.24 (d, C-3‴), 72.51 (d, C-5‴),
72.27 (d, C-6), 71.89 (d, C-2‴), 71.36 (d, C-5″), 70.45 (d, C-2″″), 70.01
(d, C-3″″), 69.80 (d, C-4‴), 69.64 (d, C-6′), 68.60 (d, C-4), 68.28 (d,
C-4″″), 68.12 (t, C-6‴), 68.04 (t, C-6″), 67.84 (d, C-7′), 67.64 (d, C-5″″),
66.03 (t, C-8), 66.01 (d, C-4′), 64.23 (d, C-5′), 61.92 (t, C-8′), 61.67
(t, C-6″″), 53.14 (q, CO2CH3), 52.60 (q, CO2CH3), 51.19 (q, OCH3), 34.23
(t, C-3), 31.90 (t, C-3′), 20.68, 20.64, 20.62, 20.59, 20.56 and 20.55
(6 q, 11C, COCH3); ESI-TOF HRMS: m/z = 1762.6029; calcd for
C81H100O42NH4+: 1762.6027.
3.11. Sodium (3-deoxy-α-D-manno-oct-2-ulopyranosyl)onate-
(2→4)-[α-D-glucopyranosyl-(1→6)-β-D-glucopyranosyl-(1→4)-α-D-
glucopyranosyl-(1→5)]-sodium (methyl 3-deoxy-α-D-manno-oct-2-
ulopyranosid)onate (19)
According to the procedure for compound 10, pentasaccharide
18 (12.0 mg, 0.007 mmol) was debenzylated in dry MeOH (1.0 mL)
over 10% Pd-C (1 mg) under an atmosphere of hydrogen (1 atm) for
4 h at rt, and deacetylated by treatment with sodium methoxide
(0.1M inMeOH, 100 μL, 10.0 μmol; 3 portions) in dryMeOH (1.0mL)
for 20 h at rt. Workup of the solution as described for 10 afforded
a residue, which was dissolved in H2O (2 mL) and treated with aq
NaOH (0.1 M, 1.0 mL) for 3 h at 0 °C followed by neutralization and
freeze-drying. The residue was desalted on a PD10 column (H2O)
and lyophilisation of the pooled fractions provided compound 19
(6.2 mg, 90%) as a colorless amorphous solid: [α]D20 + 100.8 (c 0.43,
H2O); 1H NMR (D2O, pD ~ 7.4): δ 5.25 (d, 1H, J1″,2″ 3.7 Hz, H-1″), 4.94
(d, 1H, J1″″,2″″ 3.8 Hz, H-1″″), 4.52 (d, 1H, J1‴,2‴ 8.0 Hz, H-1‴), 4.24 (app
td, 1H, J5″,4″ 10.1, J5″,6″a ~ J5″,6″b 2.4 Hz, H-5″), 4.21 (d, 1H, J5,6 2.2 Hz,
H-5), 4.03 (ddd, 1H, J7,6 9.4, J7,8b 6.3, J7,8a 3.0 Hz, H-7), 3.97–3.75 (m,
13H, H-3″, H-3″″, H-4, H-4′, H-5′, H-6″a, H-6″b, H-6‴a, H-6‴b, H-6″″a,
H-7′, H-8a, H-8′a), 3.73–3.63 (m, 6H, H-4″, H-5‴, H-5″″, H-6′, H-6″″b,
H-8′b), 3.58 (dd, 1H, J8′b,8′a 11.9 Hz, H-8b), 3.54–3.44 (m, 5H, H-2″,
H-2″″, H-3‴, H-4‴, H-6), 3.37 (app t, 1H, J4″″,3″″ ~ J4″″,5″″ 9.5 Hz, H-4″″),
3.29 (app t, J2‴,3‴ ~ 8.7 Hz, H-2‴), 3.07 (s, 3H, OCH3), 2.06–1.99 (m,
2H, H-3eq, H-3′eq), 1.94 (app t, 1H, J3ax,3eq ~ J3ax,4 12.1 Hz, H-3ax), 1.76
(app t, 1H, J3′ax,3′eq ~ J3′ax,4′ 12.5 Hz, H-3′ax); 13C NMR (D2O, pD ~ 7.4):
see Table 1; ESI-TOF HRMS: m/z = 981.2906; calcd for C35H58O30Na+:
981.2910.
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